We thus hypothesize that FGF21 may have a regulatory role in islet autophagy-mediated islet function and survival via AMPK-mTOR signaling, that is protective against glucolipotoxicity-induced islet dysfunction in obesity-associated T2DM. The gene discussed is MTOR; the disease is type 2 diabetes mellitus.